Compounding chemotherapy market to reach $9.8b by 2034

By technology, the robotic arm segment led the global market in 2024.

The compounding chemotherapy market is expected to reach $9.8b by 2034 at a compound annual growth rate of 6.4%, said Allied Market Research.

The sector’s expansion is attributed to the rising demand for personalised treatment regimens, technological developments, and the growing prevalence of cancer.

“Key developments in this market include advancements in compounding technologies, such as automated compounding devices and robotic assistance,” the report said.

By technology, the robotic arm segment led the global market in 2024 and is expected to be the fastest-growing segment during the forecast period.